NCT02778074

Brief Summary

Purpose and aims Tailored internet-based cognitive behavioural therapy (I-CBT) is a new innovative and person-centred method that is promising that may be used to decrease depression in patients with cardiovascular disease (CVD). In patients with CVD, depressive symptoms is a common co-morbidity leading to decreased wellbeing, and increased morbidity and mortality. Depressive symptoms are both underdiagnosed and undertreated in CVD patients. Earlier studies have demonstrated the efficiency of cognitive behavioural therapy (CBT) for many psychiatric conditions, but few studies have evaluated CBT in patients with CVD. The overall purpose of this study is to evaluate the effects of the tailored I-CBT program on reducing depressive symptoms and other patient reported outcomes in patients with cardiovascular disease (CVD) and to explore factors related to implementation of the I-CBT program in clinical cardiac care. The primary aim:

  • To evaluate the effects of the tailored I-CBT depression program on depressive symptoms. Secondary aims:
  • To evaluate effects on quality of life´, sleep and anxiety
  • To evaluate factors that can influence the I-CBT programs effect on depressive symptoms.
  • To gain knowledge about the I-CBT program, as perceived by patients and health care professionals.
  • To explore facilitators and barriers to the implementation of the I-CBT program in clinical practice from the perspectives of patients, health care professionals and policymakers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
144

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 16, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 19, 2016

Completed
9 months until next milestone

Study Start

First participant enrolled

February 6, 2017

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2018

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2019

Completed
5 months until next milestone

Results Posted

Study results publicly available

November 27, 2019

Completed
Last Updated

December 11, 2019

Status Verified

November 1, 2019

Enrollment Period

1.4 years

First QC Date

May 16, 2016

Results QC Date

September 24, 2019

Last Update Submit

November 29, 2019

Conditions

Keywords

Internet Cognitive Behavioural Therapy

Outcome Measures

Primary Outcomes (1)

  • Depressive Symptoms Collected With the Patient Health Questionnaire-9 (PHQ-9)

    The PHQ-9 is a nine-item instrument for measurement of depressive symptoms during the last two weeks. Each item is answered on a four graded scale where zero represents that the item do not affect the person and numbers one to three represents that the item affects the person several days to almost every day. The answers are summed to a total sum score, range 0-27, with higher numbers representing higher level of depressive symptoms. A cut off \>5 represents minor depression and a cut off \>10 represents major depression

    Score at 9 weeks follow-up

Study Arms (2)

Internet Cognitive Behavioural Therapy

EXPERIMENTAL

Participants will perform a nine-week tailored I-CBT program developed to fit CVD patients. The program consists of psychoeducation, relaxation, problem-solving and behavioral activation.

Behavioral: Internet cognitive behavioural therapy

Moderated discussion forum

PLACEBO COMPARATOR

In this arm the participants are allocated to a non mandatory discussion forum for nine weeks. Evert week will participants discuss issues regarding their CVD. Themes discussed are suggested by the study team, and a new theme is added every week. A moderator from the study group act as a supervisor and checks that issues discussed are ok. After the nine week discussion forum the participants are offered the nine week CBT program.

Behavioral: Moderated Discussion Forum

Interventions

A nine-week tailored I-CBT program for patients with CVD. The CBT program consists of the components of psychoeducation, relaxation, problem-solving and behavioural activation.

Also known as: I-CBT
Internet Cognitive Behavioural Therapy

Participants will be allocated to an internet moderated discussion forum during 9 weeks. Patients will discuss issues related to cardiovascular disease. A new topic will be discussed every week. After 9 weeks, those in the moderated discussion forum will be offered to perform the I-CBT program.

Moderated discussion forum

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • treatment for CVD according to European Society of Cardiology guidelines.
  • stable CVD (NYHA class I-III) and not having been hospitalised for CVD in in the last four weeks.
  • depressive symptoms (Patient Health Questionnaire-9 17 (PHQ-9) \> 5 points)

You may not qualify if:

  • severe CVD (NYHA IV) or another severe chronic life-threatening disease
  • severe depression assessed as requiring acute treatment
  • not being able to dedicate 3-4 hours to participate in the program

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Linkoping University

Norrköping, 601 74, Sweden

Location

Related Publications (6)

  • Mourad G, Lundgren J, Andersson G, Johansson P. Healthcare use in patients with cardiovascular disease and depressive symptoms - The impact of a nurse-led internet-delivered cognitive behavioural therapy program. A secondary analysis of a RCT. Internet Interv. 2023 Dec 5;35:100696. doi: 10.1016/j.invent.2023.100696. eCollection 2024 Mar.

  • Westas M, Mourad G, Andersson G, Lundgren J, Johansson P. The effects of internet-based cognitive behaviour therapy for depression in cardiovascular disease on symptoms of anxiety: a secondary analysis of a randomized trial. Eur J Cardiovasc Nurs. 2024 May 28;23(4):382-390. doi: 10.1093/eurjcn/zvad097.

  • Johansson P, Lundgren J, Andersson G, Svensson E, Mourad G. Internet-Based Cognitive Behavioral Therapy and its Association With Self-efficacy, Depressive Symptoms, and Physical Activity: Secondary Analysis of a Randomized Controlled Trial in Patients With Cardiovascular Disease. JMIR Cardio. 2022 Jun 3;6(1):e29926. doi: 10.2196/29926.

  • Mourad G, Lundgren J, Andersson G, Husberg M, Johansson P. Cost-effectiveness of internet-delivered cognitive behavioural therapy in patients with cardiovascular disease and depressive symptoms: secondary analysis of an RCT. BMJ Open. 2022 Apr 11;12(4):e059939. doi: 10.1136/bmjopen-2021-059939.

  • Westas M, Lundgren J, Andersson G, Mourad G, Johansson P. Effects of Internet-delivered cognitive behavioural therapy adapted for patients with cardiovascular disease and depression: a long-term follow-up of a randomized controlled trial at 6 and 12 months posttreatment. Eur J Cardiovasc Nurs. 2022 Aug 29;21(6):559-567. doi: 10.1093/eurjcn/zvab131.

  • Johansson P, Westas M, Andersson G, Alehagen U, Brostrom A, Jaarsma T, Mourad G, Lundgren J. An Internet-Based Cognitive Behavioral Therapy Program Adapted to Patients With Cardiovascular Disease and Depression: Randomized Controlled Trial. JMIR Ment Health. 2019 Oct 3;6(10):e14648. doi: 10.2196/14648.

MeSH Terms

Conditions

Cardiovascular DiseasesDepression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Results Point of Contact

Title
Dr Peter Johansson
Organization
Linkoping University

Study Officials

  • Peter Johansson, PhD

    Department of Social and Welfare Studies, Linköping University, Norrköping, Sweden

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
RN, PhD, Professor

Study Record Dates

First Submitted

May 16, 2016

First Posted

May 19, 2016

Study Start

February 6, 2017

Primary Completion

June 30, 2018

Study Completion

June 30, 2019

Last Updated

December 11, 2019

Results First Posted

November 27, 2019

Record last verified: 2019-11

Locations